­
­
­
­

Inventi Impact: Medicine

Articles

  • Inventi:hmc/31249/20
    Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend Analysis 2013-2017
    Research 2020 : April - June
    Innocent Kashongwe Murhula, Fina Mawete, Lay Ofali, Michel Kaswa, Francois Lepira Bompeka, Jean Marie Kayembe Ntumba, Zacharie Kashongwe Munogolo

    The Democratic Republic of Congo is one of the countries with a high prevalence\nof multidrug-resistant tuberculosis (MDR-TB) in Africa and worldwide.\nThis study aims to describe the trends and level of screening since 2013. This\nis a retrospective descriptive study based on quarterly reports from the provinces.\nThe number of cases, past histories, age, sex and HIV Co-infection was\nidentified. It emerges that the number of cases increases significantly but does\nnot reach the forecasts yet (912 cases of MDR/RR and XDR diagnosed in 2017\nout of 3948 cases expected with a gap of 77%). Patients with a history of TB\npredominate (63.5% in 2017); but the proportion of patients with no history\nof TB increases (36.5% in 2017). This suggests high rates among contacts.\nWomen (37.8%) and children under 15 (2.7%) are less represented. TB/HIV\nCo-infection is 12% as for sensitive cases. Efforts still need to be made to improve\nscreening.

    How to Cite this Article
    Attribution/ CC Compliant Citation: Murhula, I.K., Mawete, F., Ofali, L., Kaswa, M., Bompeka, F.L., Ntumba, J.M.K. and Munogolo, Z.K.\n(2019) Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend\nAnalysis 2013-2017. Journal of Tuberculosis Research, 7, 212-219.\nhttps://doi.org/10.4236/jtr.2019.74020\nhttp://creativecommons.org/licenses/by/4.0/\n\nSome formatting elements, header, footer, logos, dates and pagination were modified while adapting this article.
    Download Full Text